Novogen Settles Menopause Supplement Suit

Law360, New York (January 19, 2007, 12:00 AM EST) -- Australian biotechnology company Novogen Ltd. said Thursday it had settled a Canadian patent infringement lawsuit with Sante Naturelle AG over certain menopause products.

The monetary terms of the deal were undisclosed, but Novogen did say it has granted Sante a license to the patent in question. As a result, the privately held Quebec-based company will continue manufacturing and selling its non-soy based isoflavone supplements.

Among other things, isoflavones have been found to reduce such menopause symptoms as hot flashes.

“The resolution of this matter is another...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.